amgen glp 1 drug The next phase of the obesity race Amgen's weight-loss drug fails to
Description
Is compounded tirzepatide safe
2023), NNC9204-1177 (Friedrichsen et al
Additionally, while our findings are reassuring with regard to effects on newborn birthweight, we will need to exclude any potential long-term impact on childhood metabolic health. For more information: Jacqueline Maya, MD , can be reached at [email protected].
doi: 10.2337/dc14-1996 Erratum in: Diabetes Care
Available from: Accessed March 10, 2025
What Next When Metformin Isn't Enough For Type 2 Diabetes
